London, UK (CU)_ A conditional marketing approval for Xevudy (sotrovimab) has been given to GlaxoSmithKline (GSK) and Vir Biotechnology by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of acute…

GSK and Vir Biotechnology’s Xevudy Receives MHRA Conditional Marketing Authorization

New Trial Could Deliver the First Heart Disease Therapy Designed for Women

An emotional tribute to the Indian army: AR Rahman’s historic performance at the India-Pakistan border leaves thousands inspired!

Canadian BMO economist shares solid May ’26 jobs report

From Defence to AI: Reuters NEXT Europe Explores Europe’s Leadership in a Shifting World

World Cup 2026 Group G Showdown: Belgium Favored, But Egypt and Iran Could Shake Up the Standings

Related Articles

NASA Tracks Kelvin Waves Signaling Potential El Niño Across South America

Scientists to Witness Earth’s Magnetic Shield Like Never Before in Landmark Space Mission

Scientists Unlock Genetic Blueprint of the Eye, Offering Hope for Personalized Vision Therapies

How The Lancet MedZero Database Could Revolutionise Sustainable Healthcare and Climate Action Worldwide

Webb Telescope Detects Methane on Saturn-Sized Exoplanet with Earth-Like Temperatures — A First

BRICS expansion: five countries join, another 25 to follow in 2024

Chinese state media lauds India’s achievements under PM Modi!

Security alarm for India: Bangladesh frees Al-Qaeda terror group chief